Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Otorhinolaryngology

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    July 2019
  1. SUN XS, Liu SL, Luo MJ, Li XY, et al
    The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.
    Int J Radiat Oncol Biol Phys. 2019 Jul 15. pii: S0360-3016(19)33456.
    PubMed     Text format     Abstract available


  2. LEE AW, Ng WT, Pan JJ, Chiang CL, et al
    International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33428.
    PubMed     Text format     Abstract available


  3. LESTER-COLL NH, Margalit DN
    Modeling the Potential Benefits of Proton Therapy for Patients With Oropharyngeal Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2019;104:563-566.
    PubMed     Text format    


  4. GOTTGENS EL, Bussink J, Leszczynska KB, Peters H, et al
    Inhibition of CD4/CDK6 enhances radiosensitivity of HPV negative head and neck squamous cell carcinomas.
    Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33419.
    PubMed     Text format     Abstract available


    June 2019
  5. QIAN D, Wang Y, Zhao G, Cao F, et al
    Tumor Remission and tumor-infiltrating lymphocytes during chemoradiotherapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jun 19. pii: S0360-3016(19)30914.
    PubMed     Text format     Abstract available


  6. MEN K, Geng H, Zhong H, Fan Y, et al
    A deep learning model for predicting xerostomia due to radiotherapy for head-and-neck squamous cell carcinoma in the RTOG 0522 clinical trial.
    Int J Radiat Oncol Biol Phys. 2019 Jun 12. pii: S0360-3016(19)30834.
    PubMed     Text format     Abstract available


    May 2019
  7. GREWAL AS, Jones J, Lin A
    Palliative radiation therapy for head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2019 May 22. pii: S0360-3016(19)30746.
    PubMed     Text format     Abstract available


  8. MARGALIT DN, Haddad RI, Tishler RB, Chau NG, et al
    A phase I study of afatinib in combination with postoperative radiation therapy with and without weekly docetaxel in intermediate- and high-risk patients with resected squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2019 May 10. pii: S0360-3016(19)30698.
    PubMed     Text format     Abstract available


  9. HUANG XD, Li YC, Chen FP, Zheng WH, et al
    Evolution and Dosimetric Analysis of MRI-detected Brainstem Injury Following Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 May 7. pii: S0360-3016(19)30694.
    PubMed     Text format     Abstract available


  10. HALLEMEIER CL, Olsen JR, Murphy JD, Tait D, et al
    Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers.
    Int J Radiat Oncol Biol Phys. 2019;104:1-9.
    PubMed     Text format    


    April 2019
  11. ZHAO C, Miao JJ, Hua YJ, Wang L, et al
    Excellent Locoregional Control and Mild Late Toxicity after Reducing Target Volumes and Radiation Doses in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: Ten
    Int J Radiat Oncol Biol Phys. 2019 Apr 4. pii: S0360-3016(19)30570.
    PubMed     Text format     Abstract available


    March 2019
  12. MCCLELLAND S 3RD, Watson GA
    The Headache of Hearing Loss.
    Int J Radiat Oncol Biol Phys. 2019;103:796-797.
    PubMed     Text format    


  13. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    Phase I fractional dose escalation study of equipotent stereotactic radiotherapy regimens for early-stage glottic larynx cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 14. pii: S0360-3016(19)30323.
    PubMed     Text format     Abstract available


  14. SANFORD NN, Lau J, Lam MB, Juliano AF, et al
    Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
    Int J Radiat Oncol Biol Phys. 2019;103:654-668.
    PubMed     Text format     Abstract available


    February 2019
  15. BOURGIER C, Auperin A, Rivera S, Boisselier P, et al
    Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients with Head and Neck Cancer: Results of the Biology-Driven Phase Ii Clinical Trial Pravacur.
    Int J Radiat Oncol Biol Phys. 2019 Feb 15. pii: S0360-3016(19)30250.
    PubMed     Text format     Abstract available


  16. SHURYAK I, Hall EJ, Brenner DJ
    Optimized Hypofractionation can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 15. pii: S0360-3016(19)30251.
    PubMed     Text format     Abstract available


    January 2019
  17. HUANG CL, Sun ZQ, Guo R, Liu X, et al
    Plasma Epstein-Barr Virus DNA Load after Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jan 22. pii: S0360-3016(19)30048.
    PubMed     Text format     Abstract available


  18. WU L, Chung YL
    Tumor-infiltrating T-cell Receptor-beta Repertoires are Linked to the Risk of Late Chemoradiation-induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jan 14. pii: S0360-3016(19)30037.
    PubMed     Text format     Abstract available


    December 2018
  19. BAKST RL, Glastonbury CM, Parvathaneni U, Katabi N, et al
    Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2018 Dec 15. pii: S0360-3016(18)34175.
    PubMed     Text format     Abstract available


    November 2018
  20. ADJEIWAAH M, Bylund M, Lundman JA, Soderstrom K, et al
    Dosimetric Impact of MRI distortions - A study on Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2018 Nov 26. pii: S0360-3016(18)34023.
    PubMed     Text format     Abstract available


  21. BRODIN NP, Kabarriti R, Pankuch M, Schechter CB, et al
    A Quantitative Clinical Decision-support Strategy Identifying Which Oropharyngeal Head and Neck Cancer Patients may Benefit the Most from Proton Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Nov 26. pii: S0360-3016(18)34025.
    PubMed     Text format     Abstract available


  22. JI Z, Jiang Y, Tian S, Guo F, et al
    The Effectiveness and Prognostic Factors of CT-guided Radioactive Iodine-125 Seed Implantation for the Treatment of Recurrent Head and Neck Cancer after External Beam Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Nov 1. pii: S0360-3016(18)33923.
    PubMed     Text format     Abstract available


    October 2018
  23. PINDER-ARABPOUR A, Jones B, Castillo R, Castillo E, et al
    Characterizing Spatial Lung Function For Esophageal Cancer Patients Undergoing Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Oct 26. pii: S0360-3016(18)33913.
    PubMed     Text format     Abstract available


  24. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
    Eating As Treatment (EAT): a stepped-wedge, randomised controlled trial of a health behaviour change intervention provided by dietitians to improve nutrition in patients with head and neck cancer undergoing radiotherapy (TROG 12.03).
    Int J Radiat Oncol Biol Phys. 2018 Oct 5. pii: S0360-3016(18)33807.
    PubMed     Text format     Abstract available


  25. MCDOWELL LJ, Rock K, Xu W, Chan B, et al
    Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;102:340-352.
    PubMed     Text format     Abstract available


  26. OLSEN JR, Murphy JD, Huguet F, Hallemeier CL, et al
    Gastrointestinal Cancers-Carving Out the Optimal Local Therapies in the Gastrointestinal Tract.
    Int J Radiat Oncol Biol Phys. 2018;102:233-242.
    PubMed     Text format    


  27. KOTO M, Demizu Y, Saitoh JI, Suefuji H, et al
    Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
    Int J Radiat Oncol Biol Phys. 2018;102:353-361.
    PubMed     Text format     Abstract available


    September 2018
  28. JIN P, Machiels M, Crama KF, Visser J, et al
    Dosimetric benefits of mid-position compared with internal target volume strategy for esophageal cancer radiation therapy.
    Int J Radiat Oncol Biol Phys. 2018 Sep 22. pii: S0360-3016(18)33804.
    PubMed     Text format     Abstract available


  29. LU S, Wei J, Sun F, Xiao W, et al
    Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Sep 20. pii: S0360-3016(18)33762.
    PubMed     Text format     Abstract available


    July 2018
  30. TANDBERG DJ, Cui Y, Rushing CN, Hong JC, et al
    Intra-treatment response assessment with 18F-FDG PET: Correlation of semi-quantitative PET features with pathologic response of esophageal cancer to neoadjuvant chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jul 25. pii: S0360-3016(18)31640.
    PubMed     Text format     Abstract available


  31. LIU Q, Liang J, Zhou D, Krauss DJ, et al
    Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2018;101:985-997.
    PubMed     Text format     Abstract available


  32. JABBOUR SK, Apisarnthanarax S, Hallemeier CL, Huguet F, et al
    GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer.
    Int J Radiat Oncol Biol Phys. 2018;101:749-758.
    PubMed     Text format    


  33. BLITZER GC, Rosenberg SA, Anderson BM, McCulloch TM, et al
    Results From a Free Oral Cancer Screening Clinic at a Major Academic Health Center: 10 Years of Free Oral Cancer Screening at an Academic Medical Center.
    Int J Radiat Oncol Biol Phys. 2018 Jul 3. pii: S0360-3016(18)30800.
    PubMed     Text format    


  34. NANDA SS, Gandhi AK, Rastogi M, Khurana R, et al
    Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;101:593-601.
    PubMed     Text format     Abstract available


    June 2018
  35. HAN P, Wang X, Liang F, Liu Y, et al
    =Osteoradionecrosis of the Skull Base in Nasopharyngeal Carcinoma: Incidence and Risk Factors.
    Int J Radiat Oncol Biol Phys. 2018 Jun 27. pii: S0360-3016(18)31018.
    PubMed     Text format     Abstract available


  36. GRECO E, Simic T, Ringash J, Tomlinson G, et al
    Dysphagia Treatment for Patients With Head and Neck Cancer Undergoing Radiation Therapy: A Meta-analysis Review.
    Int J Radiat Oncol Biol Phys. 2018;101:421-444.
    PubMed     Text format     Abstract available


  37. CARDENAS CE, McCarroll RE, Court LE, Elgohari BA, et al
    Deep Learning Algorithm for Auto-Delineation of High-Risk Oropharyngeal Clinical Target Volumes With Built-In Dice Similarity Coefficient Parameter Optimization Function.
    Int J Radiat Oncol Biol Phys. 2018;101:468-478.
    PubMed     Text format     Abstract available


    May 2018
  38. NG WT, Tung SY, Lee V, Ngan RKC, et al
    Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.
    Int J Radiat Oncol Biol Phys. 2018 May 2. pii: S0360-3016(18)30747.
    PubMed     Text format     Abstract available


  39. XU Y, Rong X, Hu W, Huang X, et al
    Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2018 May 2. pii: S0360-3016(18)30746.
    PubMed     Text format     Abstract available


  40. WU H, Chen X, Yang X, Tao Y, et al
    Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.
    Int J Radiat Oncol Biol Phys. 2018 May 1. pii: S0360-3016(18)30737.
    PubMed     Text format     Abstract available


    April 2018
  41. BOSSI P, Miceli R, Granata R, Naimo S, et al
    Failure of Further Validation for Survival Nomograms in Oropharyngeal Cancer: Issues and Challenges.
    Int J Radiat Oncol Biol Phys. 2018;100:1217-1221.
    PubMed     Text format     Abstract available


    March 2018
  42. ZHOU GQ, Wu CF, Zhang J, Mao YP, et al
    Cost-Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow-Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Mar 30. pii: S0360-3016(18)30541.
    PubMed     Text format     Abstract available


  43. BEADLE BM, Anderson CM
    CTV Guidance for Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2018;100:903-905.
    PubMed     Text format    


  44. LIN L, Lu Y, Wang XJ, Chen H, et al
    Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines.
    Int J Radiat Oncol Biol Phys. 2018;100:891-902.
    PubMed     Text format     Abstract available


  45. YOM SS, Harari PM
    When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2018;100:838-840.
    PubMed     Text format    


  46. FANG P, Musall BC, Son JB, Moreno AC, et al
    Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30328.
    PubMed     Text format     Abstract available


  47. NG WT, Ngan RKC, Kwong DLW, Tung SY, et al
    Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:630-638.
    PubMed     Text format     Abstract available


  48. LI Y, Huang X, Jiang J, Hu W, et al
    Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Int J Radiat Oncol Biol Phys. 2018;100:621-629.
    PubMed     Text format     Abstract available


  49. MARGALIT DN, Wong SJ
    Reirradiation for Head and Neck Cancer: The Who and the How.
    Int J Radiat Oncol Biol Phys. 2018;100:618-620.
    PubMed     Text format    


  50. CAUDELL JJ, Ward MC, Riaz N, Zakem SJ, et al
    Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.
    Int J Radiat Oncol Biol Phys. 2018;100:606-617.
    PubMed     Text format     Abstract available


  51. OVERGAARD J
    In Regards to Stokes et al and Bledsoe et al.
    Int J Radiat Oncol Biol Phys. 2018;100:804-805.
    PubMed     Text format    


  52. LAIRD J, Ma J, Chau K, Chelius M, et al
    Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
    Int J Radiat Oncol Biol Phys. 2018;100:670-678.
    PubMed     Text format     Abstract available


  53. HEGDE JV, Shaverdian N, Felix C, Wang PC, et al
    Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2018;100:647-651.
    PubMed     Text format     Abstract available


    February 2018
  54. POTEZ M, Bouchet A, Wagner J, Donzelli M, et al
    Effects of Synchrotron X-Ray Micro-beam Irradiation on Normal Mouse Ear Pinnae.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30254.
    PubMed     Text format     Abstract available


  55. ZHENG B, Zhu X, Liu M, Yang Z, et al
    Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:418-426.
    PubMed     Text format     Abstract available


  56. BRODIN NP, Kabarriti R, Garg MK, Guha C, et al
    Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.
    Int J Radiat Oncol Biol Phys. 2018;100:391-407.
    PubMed     Text format     Abstract available


  57. ANDERSON CM, Sonis ST, Lee CM, Adkins D, et al
    Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:427-435.
    PubMed     Text format     Abstract available


    January 2018
  58. VARGO JA, Moiseenko V, Grimm J, Caudell J, et al
    Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.
    Int J Radiat Oncol Biol Phys. 2018 Jan 31. pii: S0360-3016(18)30107.
    PubMed     Text format     Abstract available


  59. SHEMESH R, Alon EE, Gluck I, Yakirevitch A, et al
    Endoscopic Surgery for Delayed Sinonasal Complications of Radiation Therapy for Nasopharyngeal Carcinoma: A Subjective Outcome.
    Int J Radiat Oncol Biol Phys. 2018 Jan 9. pii: S0360-3016(18)30052.
    PubMed     Text format     Abstract available


    December 2017
  60. MAGUIRE PD, Neal CR, Hardy SM, Schreiber AM, et al
    Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2017 Dec 28. pii: S0360-3016(17)34503.
    PubMed     Text format     Abstract available


  61. TENG F, Aryal M, Lee J, Lee C, et al
    Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.
    Int J Radiat Oncol Biol Phys. 2017 Dec 21. pii: S0360-3016(17)34492.
    PubMed     Text format     Abstract available


  62. QUON H, Hui X, Cheng Z, Robertson S, et al
    Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.
    Int J Radiat Oncol Biol Phys. 2017;99:1271-1278.
    PubMed     Text format     Abstract available


  63. MAN LC, Axelrod R
    Not All Head and Neck Squamous Cell Carcinomas Are Created Equal: Some Are More Aggressive.
    Int J Radiat Oncol Biol Phys. 2017;99:1063.
    PubMed     Text format    


  64. WITEK ME
    Are All Head and Neck Squamous Cell Carcinomas Created Equal?
    Int J Radiat Oncol Biol Phys. 2017;99:1059-1060.
    PubMed     Text format    


    November 2017
  65. ROUTMAN DM, Funk RK, Tangsriwong K, Lin A, et al
    Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.
    Int J Radiat Oncol Biol Phys. 2017;99:938-946.
    PubMed     Text format     Abstract available


  66. WARREN S, Hurt CN, Crosby T, Partridge M, et al
    Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:729-737.
    PubMed     Text format     Abstract available


  67. XI M, Xu C, Liao Z, Chang JY, et al
    Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:667-676.
    PubMed     Text format     Abstract available


  68. TAO Y, Auperin A, Sire C, Martin M, et al
    Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;99:590-595.
    PubMed     Text format     Abstract available


    October 2017
  69. GURNEY-CHAMPION OJ, McQuaid D, Dunlop A, Wong KH, et al
    MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017 Oct 16. pii: S0360-3016(17)34020.
    PubMed     Text format     Abstract available


    September 2017
  70. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Facility Volume and Survival in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017 Sep 28. pii: S0360-3016(17)33938.
    PubMed     Text format     Abstract available


  71. LO A, Ayre G, Ma R, Hsu F, et al
    Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Int J Radiat Oncol Biol Phys. 2017 Sep 18. pii: S0360-3016(17)33891.
    PubMed     Text format     Abstract available


    April 2017
  72. VARGO JA, Ward MC, Caudell JJ, Riaz N, et al
    A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Apr 24. pii: S0360-3016(17)30821.
    PubMed     Text format     Abstract available


  73. YOM SS
    A Larynx Best Preserved, but by Radiation or Formalin?
    Int J Radiat Oncol Biol Phys. 2017;97:889-890.
    PubMed     Text format    


    January 2017
  74. YOM SS
    The Tonsillar Fossa Battleground.
    Int J Radiat Oncol Biol Phys. 2017;97:1-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: